Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

More protein farnesyltransferase inhibitors from Warner-Lambert

May 31, 1996

Research of a recombinant fusion protein in human breast cancer disclosed

May 31, 1996

RPR-112378: A new inhibitor of tubulin polymerization

May 31, 1996

Encouraging results reported in paclitaxel and cisplatin-based therapy combination

May 31, 1996

Topotecan hydrochloride exhibits positive results in recurrent ovarian cancer patients

May 31, 1996

NSC-314622, a new topoisomerase I-targeted antitumor, described by NIH

May 31, 1996

Vinorelbine tartrate and cisplatin cocktail more effective than cisplatin alone

May 31, 1996

TAS-103, a dual inhibitor of DNA topoisomerase I and II

May 31, 1996

Rebeccamycin analogue undergoes phase I trial

May 31, 1996

Anthracycline antitumor agent FCE-23762 metabolites synthesized

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...
Lilly’s retatrutide shows solid weight loss, reduced knee pain
BioWorld
Eli Lilly and Co.’s latest phase III results for the obesity and overweight populations suggest its triple agonist, retatrutide, can deliver significant weight...